Non-redundancy within the RAS oncogene family: Insights into mutational disparities in cancer

被引:37
作者
Lau, Ken S.
Haigis, Kevin M. [1 ]
机构
[1] Massachusetts Gen Hosp, Mol Pathol Unit, Boston, MA 02114 USA
关键词
cancer; mutation; RAS; signaling; BLADDER-CARCINOMA ONCOGENE; K-RAS; N-RAS; TRANSFORMING GENES; PHOSPHOINOSITIDE; 3-KINASE; HUMAN-MELANOMA; HA-RAS; COLORECTAL-CANCER; SARCOMA-VIRUSES; SCID MICE;
D O I
10.1007/s10059-009-0143-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
The RAS family of oncoproteins has been studied extensively for almost three decades. While we know that activation of RAS represents a key feature of malignant transformation for many cancers, we are only now beginning to understand the complex underpinnings of RAS biology. Here, we will discuss emerging cancer genome sequencing data in the context of what is currently known about RAS function. Taken together, retrospective studies of primary human tissues and prospective studies of experimental models support the notion that the variable mutation frequencies exhibited by the RAS oncogenes reflect unique functions of the RAS oncoproteins.
引用
收藏
页码:315 / 320
页数:6
相关论文
共 59 条
[1]
The Hypervariable Region of K-Ras4B Is Responsible for Its Specific Interactions with Calmodulin [J].
Abraham, Sherwin J. ;
Nolet, Ryan P. ;
Calvert, Richard J. ;
Anderson, Lucy M. ;
Gaponenko, Vadim .
BIOCHEMISTRY, 2009, 48 (32) :7575-7583
[2]
PKC regulates a farnesyl-electrostatic switch on K-Ras that promotes its association with Bcl-XL on mitochondria and induces apoptosis [J].
Bivona, TG ;
Quatela, SE ;
Bodemann, BO ;
Ahearn, IM ;
Soskis, MJ ;
Mor, A ;
Miura, J ;
Wiener, HH ;
Wright, L ;
Saba, SG ;
Yim, D ;
Fein, A ;
Perez de Castro, I ;
Li, C ;
Thompson, CB ;
Cox, AD ;
Philips, MR .
MOLECULAR CELL, 2006, 21 (04) :481-493
[3]
Mutated N-ras upregulates Bcl-2 in human melanoma in vitro and in SCID mice [J].
Borner, C ;
Wadl, HS ;
Fellay, I ;
Selzer, E ;
Polterauer, P ;
Jansen, B .
MELANOMA RESEARCH, 1999, 9 (04) :347-350
[4]
Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder [J].
Braun, BS ;
Tuveson, DA ;
Kong, N ;
Le, DT ;
Kogan, SC ;
Rozmus, J ;
Le Beau, MM ;
Jacks, TE ;
Shannon, KM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (02) :597-602
[5]
HUMAN GENOME CONTAINS 4 GENES HOMOLOGOUS TO TRANSFORMING GENES OF HARVEY AND KIRSTEN MURINE SARCOMA-VIRUSES [J].
CHANG, EH ;
GONDA, MA ;
ELLIS, RW ;
SCOLNICK, EM ;
LOWY, DR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (16) :4848-4852
[6]
Ras signalling on the endoplasmic reticulum and the Golgi [J].
Chiu, VK ;
Bivona, T ;
Hach, A ;
Sajous, JB ;
Silletti, J ;
Wiener, H ;
Johnson, RL ;
Cox, AD ;
Philips, MR .
NATURE CELL BIOLOGY, 2002, 4 (05) :343-350
[7]
The dark side of Ras: regulation of apoptosis [J].
Cox, AD ;
Der, CJ .
ONCOGENE, 2003, 22 (56) :8999-9006
[8]
TRANSFORMING GENES OF HUMAN BLADDER AND LUNG-CARCINOMA CELL-LINES ARE HOMOLOGOUS TO THE RAS GENES OF HARVEY AND KIRSTEN SARCOMA-VIRUSES [J].
DER, CJ ;
KRONTIRIS, TG ;
COOPER, GM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (11) :3637-3640
[9]
In melanoma, RAS mutations are accompanied by switching signaling from BRAF to CRAF and disrupted cyclic AMP signaling [J].
Dumaz, Nicolas ;
Hayward, Robert ;
Martin, Jan ;
Ogilvie, Lesley ;
Hedley, Douglas ;
Curtin, John A. ;
Bastian, Boris C. ;
Springer, Caroline ;
Marais, Richard .
CANCER RESEARCH, 2006, 66 (19) :9483-9491
[10]
Recurrent KRAS Codon 146 mutations in human colorectal cancer [J].
Edkins, Sarah ;
O'Meara, Sarah ;
Parker, Adrian ;
Stevens, Claire ;
Reis, Marcelo ;
Jones, Sian ;
Greenman, Chris ;
Davies, Helen ;
Dalgliesh, Gillian ;
Forbes, Simon ;
Hunter, Chris ;
Smith, Raffaella ;
Stephens, Philip ;
Goldstraw, Peter ;
Nicholson, Andrew ;
Chan, Tsun Leung ;
Velculescu, Victor E. ;
Yuen, Siu Tsan ;
Leung, Suet Yi ;
Stration, Michael R. ;
Futreal, P. Andrew .
CANCER BIOLOGY & THERAPY, 2006, 5 (08) :928-932